Thinking of joining a study?

Register your interest

NCT03910296 | COMPLETED | Cancer


Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
Sponsor:

Dana-Farber Cancer Institute

Information provided by (Responsible Party):

Miryam Yusufov

Brief Summary:

The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.

Condition or disease

Cancer

Intervention/treatment

Acceptance & Commitment Therapy

Detailed Description:

This research study is a treatment development study, which is the first time investigators are developing this psychological intervention in patients with cancer, on opioid therapy. This study is being conducted to develop a psychological intervention designed specifically for individuals with cancer. The purpose of this study is to determine how practical this intervention is, to determine patient satisfaction, and test the study procedures.

Study Type : OBSERVATIONAL
Estimated Enrollment : 10 participants
Official Title : Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
Actual Study Start Date : 2019-02-20
Estimated Primary Completion Date : 2021-06-30
Estimated Study Completion Date : 2021-07-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * must be at least 18 years of age
  • * speak and comprehend English sufficiently to be able to complete the study procedures and participate in psychotherapy in English
  • * have been diagnosed with cancer
  • * have an estimated survival time ≥6 months (as approximated by palliative care clinic staff)
  • * score ≥4 on the Opioid Risk Tool (Webster \& Webster, 2005) with psychosocial distress as one of the positive items.
Exclusion Criteria
  • * untreated bipolar disorder
  • * untreated psychotic disorders
  • * untreated borderline personality disorder
  • * have an estimated survival time ≤6 months (as approximated by clinic staff).

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Location Details

NCT03910296


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Massachusetts

Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02115

Loading...